Literature DB >> 15746483

Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach.

Rochelle E Tractenberg1, Myron F Weiner, Jeffrey L Cummings, Marian B Patterson, Leon J Thal.   

Abstract

The authors' main objective was to investigate the relationship between changes in psychopathological, cognitive and activity of daily living (ADL) instrument scores over 12 months in community-dwelling persons with Alzheimer's disease (AD). A secondary objective was to evaluate the validity of dividing the Clinical Dementia Rating (CDR), a global dementia staging instrument into cognitive and functional subscores. Changes in measures of psychopathology, cognition and function between the baseline and 12-month visits were entered into these post hoc analyses of data from a one-year clinical trial to evaluate behavioral, cognitive and functional assessment instruments for use in clinical trials with AD patients. Exploratory factor analysis was used to determine whether there was independence between changes in any of these three domains of interest for this disease population; participants were a cohort of 187 well-characterized, community-dwelling persons with AD. One-year change in the behavioral symptoms of this cohort of persons with AD was statistically independent from changes in scores on cognitive and functional measures. Some evidence of independence of 12 month changes in cognitive and functional measures was found. Cognitive and functional subscores for the CDR were supported. These findings suggest that changes in behavior and cognition in dementia may have distinct pathophysiologies.

Entities:  

Mesh:

Year:  2005        PMID: 15746483      PMCID: PMC4377284          DOI: 10.1176/jnp.17.1.51

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  31 in total

Review 1.  Adult clinical neuropsychology: lessons from studies of the frontal lobes.

Authors:  Donald T Stuss; Brian Levine
Journal:  Annu Rev Psychol       Date:  2002       Impact factor: 24.137

Review 2.  Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association.

Authors:  Donald R Royall; Edward C Lauterbach; Jeffrey L Cummings; Allison Reeve; Teresa A Rummans; Daniel I Kaufer; W Curt LaFrance; C Edward Coffey
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2002       Impact factor: 2.198

Review 3.  Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update.

Authors:  Sibel Tekin; Jeffrey L Cummings
Journal:  J Psychosom Res       Date:  2002-08       Impact factor: 3.006

4.  Investigating emergent symptomatology as an outcome measure in a behavioral study of Alzheimer's disease.

Authors:  Rochelle E Tractenberg; Anthony Gamst; Ronald G Thomas; Marian Patterson; Lon S Schneider; Leon J Thal
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2002       Impact factor: 2.198

5.  An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Authors:  D Galasko; D Bennett; M Sano; C Ernesto; R Thomas; M Grundman; S Ferris
Journal:  Alzheimer Dis Assoc Disord       Date:  1997       Impact factor: 2.703

Review 6.  Cholinesterase inhibitors: A new class of psychotropic compounds.

Authors:  J L Cummings
Journal:  Am J Psychiatry       Date:  2000-01       Impact factor: 18.112

7.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

8.  Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease.

Authors:  S Tekin; M S Mega; D M Masterman; T Chow; J Garakian; H V Vinters; J L Cummings
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

9.  Emergent psychopathology in Alzheimer's disease patients over 12 months associated with functional, not cognitive, changes.

Authors:  Rochelle E Tractenberg; Myron F Weiner; Marian B Patterson; Anthony Gamst; Leon J Thal
Journal:  J Geriatr Psychiatry Neurol       Date:  2002       Impact factor: 2.680

10.  The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease.

Authors:  P N Tariot; J L Mack; M B Patterson; S D Edland; M F Weiner; G Fillenbaum; L Blazina; L Teri; E Rubin; J A Mortimer
Journal:  Am J Psychiatry       Date:  1995-09       Impact factor: 18.112

View more
  14 in total

1.  Social cognition in Alzheimer's disease: a separate construct contributing to dependence.

Authors:  Stephanie Cosentino; Laura B Zahodne; Jason Brandt; Deborah Blacker; Marilyn Albert; Bruno Dubois; Yaakov Stern
Journal:  Alzheimers Dement       Date:  2014-03-18       Impact factor: 21.566

2.  Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without Dementia.

Authors:  Maria Vassilaki; Jeremiah A Aakre; Walter K Kremers; Michelle M Mielke; Yonas E Geda; Mary M Machulda; David S Knopman; Preciosa M Coloma; Barbara Schauble; Prashanthi Vemuri; Val J Lowe; Clifford R Jack; Ronald C Petersen; Rosebud O Roberts
Journal:  J Am Geriatr Soc       Date:  2018-11-21       Impact factor: 5.562

3.  Benzodiazepine Use and Cognitive Decline in Elderly With Normal Cognition.

Authors:  Yuhai Zhang; Xiao-Hua Zhou; Dana H Meranus; Linbo Wang; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Apr-Jun       Impact factor: 2.703

4.  Seeing with new eyes: finding a path to early intervention trials in Alzheimer's disease.

Authors:  J M Cedarbaum; G Crans; M Grundman
Journal:  J Nutr Health Aging       Date:  2010-04       Impact factor: 4.075

5.  Independent contributions of neural and "higher-order" deficits to symptoms in Alzheimer's disease: a latent variable modeling approach.

Authors:  Rochelle E Tractenberg; Paul S Aisen; Myron F Weiner; Jeffrey L Cummings; Gregory R Hancock
Journal:  Alzheimers Dement       Date:  2006-10       Impact factor: 21.566

6.  Agreement in cognitive and clinical assessments in Alzheimer's disease.

Authors:  Rochelle E Tractenberg; Paul S Aisen
Journal:  Dement Geriatr Cogn Disord       Date:  2009-03-17       Impact factor: 2.959

7.  Neuropsychiatric correlates of white matter hyperintensities in Alzheimer's disease.

Authors:  Yosef A Berlow; William M Wells; James M Ellison; Young Hoon Sung; Perry F Renshaw; David G Harper
Journal:  Int J Geriatr Psychiatry       Date:  2010-08       Impact factor: 3.485

Review 8.  For whom and for what the definition of severe dementia is useful: an EDCON consensus.

Authors:  E J Byrne; M Benoit; J M Lopez Arrieta; C Geraldi; R Koopmans; Y Rolland; N Sartorius; G Stoppe; P Robert
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

9.  The ADAS-Cog revisited: novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials.

Authors:  Nandini Raghavan; Mahesh N Samtani; Michael Farnum; Eric Yang; Gerald Novak; Michael Grundman; Vaibhav Narayan; Allitia DiBernardo
Journal:  Alzheimers Dement       Date:  2012-11-02       Impact factor: 21.566

10.  Functional reserve: The residual variance in instrumental activities of daily living not explained by brain structure, cognition, and demographics.

Authors:  A Zarina Kraal; Lauren Massimo; Evan Fletcher; Carmen I Carrión; Luis D Medina; Dan Mungas; Brandon E Gavett; Sarah Tomazewski Farias
Journal:  Neuropsychology       Date:  2021-01       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.